Form 8-K - Current report:
SEC Accession No. 0001104659-26-001076
Filing Date
2026-01-06
Accepted
2026-01-06 07:15:11
Documents
42
Period of Report
2026-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20260106x8k.htm   iXBRL 8-K 56022
2 EX-99.1 acrs-20260106xex99d1.htm EX-99.1 28539
3 EX-99.2 acrs-20260106xex99d2.htm EX-99.2 39132
4 GRAPHIC acrs-20260106xex99d1001.jpg GRAPHIC 5588
5 GRAPHIC acrs-20260106xex99d1002.jpg GRAPHIC 12836
6 GRAPHIC acrs-20260106xex99d2g001.jpg GRAPHIC 123896
7 GRAPHIC acrs-20260106xex99d2g002.jpg GRAPHIC 250727
8 GRAPHIC acrs-20260106xex99d2g003.jpg GRAPHIC 134432
9 GRAPHIC acrs-20260106xex99d2g004.jpg GRAPHIC 143650
10 GRAPHIC acrs-20260106xex99d2g005.jpg GRAPHIC 122049
11 GRAPHIC acrs-20260106xex99d2g006.jpg GRAPHIC 136734
12 GRAPHIC acrs-20260106xex99d2g007.jpg GRAPHIC 112533
13 GRAPHIC acrs-20260106xex99d2g008.jpg GRAPHIC 185351
14 GRAPHIC acrs-20260106xex99d2g009.jpg GRAPHIC 114877
15 GRAPHIC acrs-20260106xex99d2g010.jpg GRAPHIC 146591
16 GRAPHIC acrs-20260106xex99d2g011.jpg GRAPHIC 152094
17 GRAPHIC acrs-20260106xex99d2g012.jpg GRAPHIC 134629
18 GRAPHIC acrs-20260106xex99d2g013.jpg GRAPHIC 137875
19 GRAPHIC acrs-20260106xex99d2g014.jpg GRAPHIC 117754
20 GRAPHIC acrs-20260106xex99d2g015.jpg GRAPHIC 153597
21 GRAPHIC acrs-20260106xex99d2g016.jpg GRAPHIC 110752
22 GRAPHIC acrs-20260106xex99d2g017.jpg GRAPHIC 119989
23 GRAPHIC acrs-20260106xex99d2g018.jpg GRAPHIC 90899
24 GRAPHIC acrs-20260106xex99d2g019.jpg GRAPHIC 80372
25 GRAPHIC acrs-20260106xex99d2g020.jpg GRAPHIC 122577
26 GRAPHIC acrs-20260106xex99d2g021.jpg GRAPHIC 162129
27 GRAPHIC acrs-20260106xex99d2g022.jpg GRAPHIC 179829
28 GRAPHIC acrs-20260106xex99d2g023.jpg GRAPHIC 148810
29 GRAPHIC acrs-20260106xex99d2g024.jpg GRAPHIC 196598
30 GRAPHIC acrs-20260106xex99d2g025.jpg GRAPHIC 126418
31 GRAPHIC acrs-20260106xex99d2g026.jpg GRAPHIC 123891
  Complete submission text file 0001104659-26-001076.txt   5272682

Data Files

Seq Description Document Type Size
32 EX-101.SCH acrs-20260106.xsd EX-101.SCH 2680
33 EX-101.LAB acrs-20260106_lab.xml EX-101.LAB 15911
34 EX-101.PRE acrs-20260106_pre.xml EX-101.PRE 10218
44 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20260106x8k_htm.xml XML 4792
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 26509394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)